vaccine, japanese encephalitis




Four Star
Concise Prescribing Info
Live, attenuated Japanese encephalitis vaccine
Prophylaxis of Japanese encephalitis in patient ≥9 mth.
Dosage/Direction for Use
SC inj Primary vaccination Patient ≥9 mth 0.5 mL single inj. Booster Adult No need for a booster dose up to 5 yr after administration of a single dose of Imojev. Patient ≥9 mth to <17 yr 1 dose 12-24 mth after primary vaccination.
History of severe allergic reaction to any component of the vaccine or after previous administration of the vaccine. Postpone vaccination in case of febrile or acute disease. Congenital or acquired immune deficiency impairing cellular immunity, including immunosuppressive therapies eg, chemotherapy, high doses of systemic corticosteroids given for ≥14 days. Symptomatic HIV infection or asymptomatic HIV infection accompanied by evidence of impaired immune function. Pregnancy & lactation.
Special Precautions
Do not administer intravascularly. For patients treated w/ high dose of systemic corticosteroid given for ≥14 days, wait at least 1 mth following interruption of therapy before vaccination. Childn <9 mth.
Adverse Reactions
Fatigue, malaise, inj site pain; headache; myalgia. Feeling hot, chills, inj site erythema, pruritus, swelling, & bruising; dizziness; arthralgia; diarrhoea, nausea, abdominal pain, vomiting; pharyngolaryngeal pain, dyspnoea, rhinorrhoea, cough, wheezing, nasal congestion; rash.
Drug Interactions
Vaccination must not be performed w/in 6 wk & preferably not w/in 3 mth of inj of Ig or blood products containing Ig eg, blood or plasma to avoid neutralisation of the attenuated viruses.
MIMS Class
Vaccines, Antisera & Immunologicals
ATC Classification
J07BA - Encephalitis vaccines ; Used for active immunizations.
Imojev inj
(single-dose vaccine in vial + diluent in separate vial + 1 syringe + 2 separate needles/box) 1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in